...
首页> 外文期刊>Molecular and Cellular Endocrinology >Epigenetic reactivation of p21(CIP1/WAF1) and KLOTHO by a combination of bioactive dietary supplements is partially ER alpha-dependent in ER alpha-negative human breast cancer cells
【24h】

Epigenetic reactivation of p21(CIP1/WAF1) and KLOTHO by a combination of bioactive dietary supplements is partially ER alpha-dependent in ER alpha-negative human breast cancer cells

机译:结合生物活性膳食补充剂对p21(CIP1 / WAF1)和KLOTHO进行表观遗传激活在ER alpha阴性人类乳腺癌细胞中部分依赖ER alpha

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Available treatment strategies against estrogen receptor (ER)-negative breast cancer patients are limited due to their poor response to hormonal therapy. We have shown previously that the combinations of green tea polyphenols (GTPs), a dietary DNA methyltransferase inhibitor, and sulforaphane (SFN), a dietary histone deacetylase inhibitor, reactivate ER alpha expression in ER alpha-negative MDA-MB-231 cells. Here, we investigated the functional significance of ERa reactivation in the reactivation of silenced tumor suppressor genes (TSGs) in ER alpha-negative human breast cancer cells. We found that the treatment of MDA-MB-231 cells with the combinations of GTPs and SFN leads to the reactivation of silenced TSGs such as p21(CIP1/WAF1) and KLOTHO through active chromatin modifications. Further, GTPs- and SFN-mediated reactivation of TSGs was, at least in part, dependent on ERa reactivation in ERa-negative MDA-MB-231 cells. Collectively, our findings suggest that a novel combination of bioactive dietary supplements could further be explored as an effective therapeutic option against hormonal refractory breast cancer. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
机译:由于雌激素受体(ER)阴性的乳腺癌患者对激素治疗的反应较差,因此可用的治疗策略有限。先前我们已经表明,饮食中的DNA甲基转移酶抑制剂绿茶多酚(GTP)和饮食中的组蛋白脱乙酰基酶抑制剂萝卜硫烷(SFN)的组合可重新激活ERα阴性MDA-MB-231细胞中的ER alpha表达。在这里,我们研究了ERα激活在ER alpha阴性人类乳腺癌细胞中沉默的抑癌基因(TSG)的激活中的功能意义。我们发现,用GTP和SFN组合治疗MDA-MB-231细胞可通过活性染色质修饰导致沉默的TSG(如p21(CIP1 / WAF1)和KLOTHO)重新激活。此外,GTP和SFN介导的TSG的重新激活至少部分取决于Era阴性MDA-MB-231细胞中的ERa重新激活。总的来说,我们的发现表明,可以进一步探索一种新型的生物活性膳食补充剂组合,作为对抗激素难治性乳腺癌的有效治疗选择。 (C)2015 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号